Comparison of In‐Office and General Anesthesia Biopsies for Oropharyngeal Squamous Cell Carcinoma in a Public Healthcare System
Open Access
- 28 April 2026
- journal article
- Published by Wiley in Head & Neck
- Vol. 48 (10) , 2792-2799
Abstract
Background: We compared treatment delays, costs, and management impact between oropharyngeal squamous cell carcinoma (OPSCC) patients undergoing in‐office versus general anesthesia panendoscopy‐guided biopsies in two large tertiary centers in a public healthcare system. Methods: All OPSCC patients included were treated between 2010 and 2024 with either curative radiation alone or chemoradiation. Results: Demographic and tumor characteristics were comparable, except for smaller tumors in the panendoscopy group ( n = 36) compared to the in‐office group ( n = 37) (mean size; 29.4 mm vs. 36.6 mm, respectively; difference −7.2 mm [95% CI, −11.3 to −3.1]). The panendoscopy group experienced substantially longer treatment initiation delays (mean days; 70.1 days vs. 44.5 days; difference 25.7 days [95% CI 13.0 to 38.2]). No additional synchronous tumors were detected through panendoscopy. Panendoscopy incurred a mean additional cost of 2025CAD $3886. Conclusions: Panendoscopy for OPSCC prolongs treatment initiation, incurs additional expenses, and provides no incremental synchronous tumor detection. When clinically feasible, in‐office biopsies should be preferred.Keywords
Funding Information
- Université de Montréal
This publication has 14 references indexed in Scilit:
- In-Office vs Operating Room Time to Treatment of Oropharyngeal BiopsiesJAMA Otolaryngology–Head & Neck Surgery, 2024
- Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity CancerJAMA Otolaryngology–Head & Neck Surgery, 2023
- Global epidemiologic patterns of oropharyngeal cancer incidence trendsJNCI: Journal of the National Cancer Institute, 2023
- Incidence of synchronous malignancies found during triple endoscopy in head and neck cancerAmerican Journal of Otolaryngology, 2022
- PET/CTversus triple endoscopy in initial workup ofHPV+ oropharyngeal squamous cell carcinomaHead & Neck, 2022
- Association of Delayed Time to Treatment Initiation With Overall Survival and Recurrence Among Patients With Head and Neck Squamous Cell Carcinoma in an Underserved Urban PopulationJAMA Otolaryngology–Head & Neck Surgery, 2019
- Association of Treatment Delays With Survival for Patients With Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2019
- National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiationOral Oncology, 2018
- Reliability of office‐based narrow‐band imaging–guided flexible laryngoscopic tissue samplingsThe Laryngoscope, 2016
- In‐office biopsy of upper airway lesions: Safety, tolerance, and effect on time to treatmentThe Laryngoscope, 2014